War‑Driven Supply Chain Disruptions Push Paracetamol Prices Up 96% in India

Middle East geopolitical tensions are causing ripples across global commerce, directly affecting the pharmaceutical industry. The region, particularly the Persian Gulf, serves as a vital hub for petrochemical feedstocks, which are crucial components in drug manufacturing. Blockades, such as that of the Strait of Hormuz, disrupt the flow of essential resources, making conflict in this area a direct threat to global pharmaceutical production. These disruptions extend beyond raw materials to critical sea and air routes in the Gulf, altering established logistics pathways for medicines worldwide, many of which require sensitive handling like an unbroken cold chain.

The cost of paracetamol in India has increased by about 96 percent due to these compounded supply chain pressures. Pharmaceutical production relies heavily on petrochemical feedstocks, with a significant portion originating from the Persian Gulf. This reliance creates a direct vulnerability to regional instability. Furthermore, the transport of finished medicines is highly susceptible to these disruptions. About 35 percent of all pharmaceuticals, and roughly 90 percent of critical or life-saving medicines and vaccines, move by air cargo. Widespread flight cancellations, airspace closures, and a looming jet fuel crisis directly impact these sensitive air logistics corridors, particularly those transiting the Middle East.

These disruptions currently manifest as increased shipping costs, longer transit times, and necessary rerouting, rather than widespread physical shortages. The pharmaceutical supply chain, while not facing immediate systemic collapse, absorbs these higher operational costs. This economic strain impacts the final price of medicines, especially generic drugs where profit margins are already thin; any relative increase in transport costs can translate to a proportionally larger price hike for consumers. The sector must adapt to these escalating logistical complexities and increased expenses. Observers will continue to monitor how geopolitical stability in the Middle East impacts the sustained availability and affordability of essential drugs globally.